Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β

por Muñoz, Úrsula, Sebal, Cristina, Escudero, Esther, Urcelay, Elena, Arroyo, Rafael, García-Martínez, Maria A., Quintana, Francisco J., Álvarez-Lafuente, Roberto, Sádaba, Maria Cruz
Publicado 2022

Serum antibodies to phosphatidylcholine in MS

por Sádaba, Maria Cruz, Rothhammer, Veit, Muñoz, Úrsula, Sebal, Cristina, Escudero, Esther, Kivisäkk, Pia, Garcia Sanchez, Maria Isabel, Izquierdo, Guillermo, Hauser, Stephen L., Baranzini, Sergio E., Oksenberg, Jorge R., Álvarez-Lafuente, Roberto, Bakshi, Rohit, Weiner, Howard L., Quintana, Francisco J.
Publicado 2020